herapeutic Mitochondria Transplantation (TMT) company
cellvie has raised €9.4M across 2 funding rounds from 4 investors, most recently a round in Sep 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-09-10 | Other | €4.3M | Beiersdorf Venture Capital,Kizoo Technology Capital,Taiho Ventures | View deal → |
| 2023-02-06 | Other | €5.1M | Kizoo Technology Capital GmbH,Taiho Ventures | View deal → |
